BiondVax announces Second Quarter 2022 Financial Results and Provides Business Update
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the...
Source: prnewswire.com